You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 2, February 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Growth in Glycogen-Storage Disease Type 1

Evaluation of Endocrine Function

Richard N. Fine, MD; S. Douglas Frasier, MD; George N. Donnell, MD

Am J Dis Child. 1969;117(2):169-177.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

GLYCOGEN-storage disease (GSD) type 1 is an inborn error of carbohydrate metabolism resulting in diminished activity of the enzyme glucose-6-phosphatase in the liver,1 kidney,2 and small intestine.3 Clinically, the disease is characterized by hypoglycemic seizures, lactic acidosis, hyperuricemia,4 hyperlipidemia,5 hepatomegaly, short stature, and retarded development of secondary sex characteristics.

The pattern of growth and sexual development in patients with GSD type 1 is suggestive of a deficiency of one or more of the pituitary trophic hormones. Therefore we have investigated those functions which influence growth and sexual development in patients with this disorder.

Formula genital defect may be strengthened.

Report of Cases

Four patients (patient 1, a 21-year-old white man; patient 2, a 17-year-old oriental girl; pa tient 3, a 14-year-old white girl; and patient 4, a 13-year-old white boy) with GSD, type 1, who met the following biochemical criteria were studied: (1) no increase in the . . . [Full Text PDF of this Article]


Author Affiliations

Los Angeles

From the Division of Metabolic-Renal Diseases, Department of Pediatrics, Childrens Hospital of Los Angeles (Drs. Fine and Donnell); the Department of Pediatrics, School of Medicine, University of Southern California, Los Angeles (Drs. Fine, Frasier, and Donnell); and the Center for Health Sciences, and Pacific State Hospital, Pomona, Calif (Dr. Frasier).


Footnotes

Received for publication Nov 15, 1967.

Reprint requests to Childrens Hospital of Los Angeles, 4650 Sunset Blvd, Los Angeles 90027 (Dr. Fine).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.